189
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Structural insights of Staphylococcus aureus FtsZ inhibitors through molecular docking, 3D-QSAR and molecular dynamics simulations

, , &
Pages 61-70 | Received 26 Oct 2017, Accepted 28 Dec 2017, Published online: 25 Jan 2018

References

  • Erickson HP. FtsZ, a tubulin homologue in prokaryote cell division. Trends Cell Bio. 1997;7:362–367.
  • Lutkenhaus J, Mukherjee A, Neidhard FC. Emerging trends in antibacterial discovery: answering the call to arms. Washington DC: ASM Press; 1996. p. 1615–1627.
  • Rothfield LI, Justice SS. Bacterial cell division: the cycle of the ring. Cell. 1997;88:581–584.
  • Hale CA, de Boer PA. Recruitment of ZipA to the septal ring of Escherichia coli is dependent on FtsZ and independent of FtsA. J Bacteriol. 1999;181:167–176.
  • Qiang S, Wang C, Venter H, et al. Synthesis and biological evaluation of novel FtsZ-targeted 3-arylalkoxy-2,6-difluorobenzamides as potential antimicrobial agents. Chem Biol Drug Des. 2016; 87:257–264.
  • Xin L, Juzheng S, Guihua H, et al. Design, synthesis and antibacterial activity of cinnamaldehyde derivatives as inhibitors of the bacterial cell division protein FtsZ. Eur Jour Med Chem. 2015;97:32–41.
  • Wang Y, Yan M, Ma R, et al. Synthesis and antibacterial activity of novel 4-bromo-1H-indazole derivatives as FtsZ inhibitors. Arch Pharm Chem Life Sci. 2015;348:266–274.
  • Vijayalakshmi P, Nisha J, Rajalakshmi M. Virtual screening of potential inhibitor against FtsZ protein from Staphylococcus aureus. Interdiscip Sci Comput Life Sci. 2014;6:331–339.
  • Andrades J, Campanini J, Vásquez D, et al. A combined CoMFA and CoMSIA 3D-QSAR study of benzamide type antibacterial inhibitors of the FtsZ protein in drug-resistant Staphylococcus aureus. SAR QSAR Environ Res. 2015;26:925–942.
  • Caflisch A, Ehrhardt C. Structure-based combinatorial ligand design. In: Veerapandian P, editor. Structure-based drug design. New York: Marcel Dekker; 1997. p. 541–558.
  • Cho SJ, Garsia MLS, Bier J, et al. Structure-based alignment and comparative molecular field analysis of acetylcholinesterase inhibitors. J Med Chem. 1996;39:5064–5071.
  • Sippl W, Contreras JM, Parrot I, et al. Structure-based 3D QSAR and design of novel acetylcholinesterase inhibitors. J Comput Aided Mol Des. 2001;15:395–410.
  • Sippl W. Receptor-based 3D QSAR analysis of estrogen receptor ligands merging the accuracy of receptor-based alignments with the computational efficiency of ligand-based methods. J Comput Aided Mol Des. 2000;14:559–572.
  • Cramer RD, Patterson DE, Bunce JD. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc. 1988;110:5959–5967.
  • Cramer RD III, Patterson DE, Bunce JD. Cross validation, bootstrapping, and partial least squares compared with multiple regression in conventional QSAR studies. Quant Struct Act Relat. 1988;7:18–25.
  • Klebe G, Abraham U, Mietzer T. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem. 1994;37:4130–4146.
  • Wold S, Johansson A, Cocchi M. PLS-partial least squares projection to latent structures. In: Kubinyl H, editor. 3D-QSAR in drug design: theory, methods and application. ESCOM; 1993. p. 523–550.
  • Matsui T, Yamane j, Mogi N, et al. Structural reorganization of the bacterial cell-division protein FtsZ from Staphylococcus aureus. Acta Crystallogr D Biol Crystallogr. 2012;68:1175–1188.
  • Glide, Version 4.0. New York (NY): Schrödinger LLC; 2005
  • Sree Kanth S, Vijjulatha M. Molecular docking and 3D-QSAR studies on triazolinone and pyridazinone, non-nucleoside inhibitor of HIV-1 reverse transcriptase. J Mol Model. 2010;16:1169–1178.
  • Friesner RA, Banks JL, Murphy RB, et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem. 2004;47:1739–1749.
  • Stokes NR, Baker N, Bennett JM, et al. Design, synthesis and structure-activity relationships of substituted oxazole-benzamide antibacterial inhibitors of FtsZ. Bioorg Med Chem Lett. 2014;24:353–359.
  • Czaplewski LG, Collins I, Boyd EA, et al. Antibacterial alkoxybenzamide inhibitors of the essential bacterial cell division protein FtsZ. Bioorg Med Chem Lett. 2009;19:524–527.
  • Sybyl-X 2.1. St. Louis (MO): Tripos Associates; 2012.
  • Gasteiger J, Marsili M. Iterative partial equalization of orbital electro negativity - a rapid access to atomic charges. Tetrahedron. 1980;36:3219–3228.
  • Ramesh I, Srilata B, Sree Kanth S, et al. Molecular docking, 3D QSAR and dynamics simulation studies of imidazo-pyrrolopyridines as janus kinase 1 (JAK 1) inhibitors. Comput Biol Chem. 2016;64:33–46.
  • Desmond 3.8. New York (NY): D. E. Shaw Research; 2014.
  • Kaminski GA, Friesner RA. Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides. J Phys Chem. 2001;105:6474–6487.
  • Strahan GD, Keniry MA, Shafer RH. NMR structure refinement and dynamics of the K+-[d(G3T4G3)]2 quadruplex via particle mesh Ewald molecular dynamics simulations. Biophys J. 1998;75:968–981.
  • Berendsen HJC, Grigera JR, Straatsma TP. The missing term in effective pair potentials. J Phys Chem. 1987;91:6269–6271.
  • Andersen HC. Rattle: a “velocity” version of the shake algorithm for molecular dynamics calculations. J Comput Phys 1983;52:24–34.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.